dolmen
menarini international operations luxembourg s.a. - deksketoprofenas - granulės paketėlyje - 25 mg - dexketoprofen
tenofovir disoproxil sandoz
sandoz d.d. - tenofoviro dizoproksilis - plėvele dengtos tabletės - 245 mg - tenofovir disoproxil
kalydeco
vertex pharmaceuticals (ireland) limited - ivakaftoras - cistinė fibrozė - kiti kvėpavimo sistemos produktai - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 ir 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 ir 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.
nimesil
laboratori guidotti s.p.a. - nimesulidas - granulės geriamajai suspensijai - 100 mg - nimesulide
oxaliplatin accord
accord healthcare b.v. - oksaliplatina - koncentratas infuziniam tirpalui - 5 mg/ml - oxaliplatin
carboplatin accord
accord healthcare b.v. - karboplatina - koncentratas infuziniam tirpalui - 10 mg/ml - carboplatin
topotecan accord
accord healthcare b.v. - topotekanas - koncentratas infuziniam tirpalui - 1 mg/ml - topotecan
gemcitabine accord
accord healthcare b.v. - gemcitabinas - milteliai infuziniam tirpalui - 2000 mg; 200 mg; 1000 mg - gemcitabine
gemcitabine accord
accord healthcare b.v. - gemcitabinas - koncentratas infuziniam tirpalui - 100 mg/ml - gemcitabine